Guardant Health

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Guardant Health 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About GH

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. 

CEO
Helmy Eltoukhy
CEOHelmy Eltoukhy
Employees
2,506
Employees2,506
Headquarters
Palo Alto, California
HeadquartersPalo Alto, California
Founded
2011
Founded2011
Employees
2,506
Employees2,506

GH Key Statistics

Market cap
12.31B
Market cap12.31B
Price-Earnings ratio
-28.31
Price-Earnings ratio-28.31
Dividend yield
Dividend yield
Average volume
2.01M
Average volume2.01M
High today
$94.02
High today$94.02
Low today
$86.42
Low today$86.42
Open price
$87.91
Open price$87.91
Volume
1.74M
Volume1.74M
52 Week high
$120.74
52 Week high$120.74
52 Week low
$36.36
52 Week low$36.36

Stock Snapshot

With a market cap of 12.31B, Guardant Health(GH) trades at $93.99. The stock has a price-to-earnings ratio of -28.31.

On 2026-04-03, Guardant Health(GH) stock moved within a range of $86.42 to $94.02. With shares now at $93.99, the stock is trading +8.8% above its intraday low and -0.0% below the session's peak.

Trading activity shows a volume of 1.74M, compared to an average daily volume of 2.01M.

Over the past 52 weeks, Guardant Health(GH) stock has traded between a high of $120.74 and a low of $36.36.

Over the past 52 weeks, Guardant Health(GH) stock has traded between a high of $120.74 and a low of $36.36.

GH News

Simply Wall St 3d
The Bull Case For Guardant Health Could Change Following Japan’s ENHERTU Approval Using Its AI Data

In late March 2026, Guardant Health reported that real-world evidence from its InfinityAI and Guardant360 platforms helped support Japan’s approval of Daiichi S...

The Bull Case For Guardant Health Could Change Following Japan’s ENHERTU Approval Using Its AI Data

Analyst ratings

88%

of 26 ratings
Buy
88.5%
Hold
11.5%
Sell
0%

People also own

Based on the portfolios of people who own GH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.